Thomas Meier, PhD
Founder, Chairman of the Board and the Scientific Committee, Member of the Compensation and Audit & Compliance Committees
Read moreWe are focusing on the development of treatments for neuromuscular diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD).
We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.
Founder, Chairman of the Board and the Scientific Committee, Member of the Compensation and Audit & Compliance Committees
Read moreBoard Member and Chairman of the Audit & Compliance Committee
Read moreBoard Member and Chairman of the Compensation Committee
Read moreBoard Member
Read moreChief Executive Officer
Read moreChief Financial Officer
Read moreChief Medical Officer
Read moreChief Legal Officer & Corporate Secretary (from 1.8.2024)
Read moreChief Technology Officer (since 1.1.2024)
Read moreChief Commercial Officer (since 1.1.2024)
Read more